Latest filing published 15 Aug 2011 for Jazz Pharmaceuticals plc.
Insider track record
No signal scores available.
Mark G. Eller: trading record in brief
Mark G. Eller is a declared insider of Jazz Pharmaceuticals plc, with filings sourced from SEC (Form 4). Over a trading history stretching from 31 May 2011 to 13 August 2011, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 15 August 2011 came the latest disclosure, an option exercise in Jazz Pharmaceuticals plc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark G. Eller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 690 shares0Common StockSEC:0001232524-11-000030:0
- 3,461 shares@ US$0.85Common StockSEC:0001232524-11-000028:0
2 of 2 declarations
